- Home
- RGNX vs IDR Comparison
RGNX vs IDR Comparison
Compare RGNX & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- IDR
- Stock Information
- Founded
- RGNX 2008
- IDR 1996
- Country
- RGNX United States
- IDR United States
- Employees
- RGNX N/A
- IDR N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- IDR Precious Metals
- Sector
- RGNX Health Care
- IDR Basic Materials
- Exchange
- RGNX Nasdaq
- IDR Nasdaq
- Market Cap
- RGNX 451.1M
- IDR 378.0M
- IPO Year
- RGNX 2015
- IDR N/A
- Fundamental
- Price
- RGNX $12.50
- IDR $40.86
- Analyst Decision
- RGNX Strong Buy
- IDR Strong Buy
- Analyst Count
- RGNX 8
- IDR 1
- Target Price
- RGNX $28.50
- IDR $17.50
- AVG Volume (30 Days)
- RGNX 525.7K
- IDR 616.8K
- Earning Date
- RGNX 11-05-2025
- IDR 11-03-2025
- Dividend Yield
- RGNX N/A
- IDR N/A
- EPS Growth
- RGNX N/A
- IDR 57.55
- EPS
- RGNX N/A
- IDR 0.64
- Revenue
- RGNX $155,782,000.00
- IDR $30,496,328.00
- Revenue This Year
- RGNX $203.79
- IDR $21.91
- Revenue Next Year
- RGNX $0.72
- IDR $5.47
- P/E Ratio
- RGNX N/A
- IDR $66.28
- Revenue Growth
- RGNX 74.95
- IDR 59.64
- 52 Week Low
- RGNX $5.04
- IDR $9.67
- 52 Week High
- RGNX $12.28
- IDR $42.83
- Technical
- Relative Strength Index (RSI)
- RGNX 76.74
- IDR 74.53
- Support Level
- RGNX $10.24
- IDR $32.30
- Resistance Level
- RGNX $11.00
- IDR $35.47
- Average True Range (ATR)
- RGNX 0.63
- IDR 2.76
- MACD
- RGNX 0.28
- IDR 0.81
- Stochastic Oscillator
- RGNX 93.57
- IDR 84.51
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.